Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications. Codexis is based in Redwood City, CA and was incorporated in 2002. It went public in April 2010 on NASDAQ, and in October, acquired Maxygen's MolecularBreeding technology portfolio. Codexis uses directed evolution to develop its enzymes. Using this method, scientists genetically engineer genes, then screen the enzymes produced to see if it creates the properties needed for a specific reaction. Their protein engineering platform, called CodeEvolver, uses machine learning and high-throughput experimentation to learn protein sequence changes and their impacts on protein function. More information...
According to PR-model, codexis.com is ranked 2,290,393rd in multilingual Wikipedia, in particular this website is ranked 1,272,573rd in English Wikipedia.
The website is placed before freedommuseum.us and after williemaar.com in the BestRef global ranking of the most important sources of Wikipedia.
